Botox Cosmetics Production RNA 
The Pharma Data
APRIL 30, 2021
“Our new products are delivering impressive performance and we are on the cusp of potential commercial approvals for more than a dozen new products or indications over the next two years – including five expected approvals in 2021.” Global Botox Cosmetic net revenues were $477 million , an increase of 44.7
XTalks
AUGUST 2, 2023
Most of the company’s revenue comes from the manufacture and sale of biopharmaceutical products. They are committed to capitalizing on growth opportunities primarily through the advancement of their own product pipeline and constantly improving their existing products, as well as through business development activities.
Expert insights. Personalized for you.
40 
Let's personalize your content